This is the second biosimilar submission developed by the partnership that has been accepted for review in Europe, global pharma major Mylan and Biocon said in a statement today.
first published: Aug 25, 2016 08:46 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Over 150 Points From Day's High But Gains For 6th Day| IT Stocks Surge|Closing Bell Live
Jigar Mistry flags potential risk to markets and what investors need to be cautious about
Will Nifty Clinch All-Time High As GIFT Nifty Signals Big Gap Up? HUL Q2 Today| Opening Bell Live
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
